PROTAC Compounds Targeting TRK for Use in Cancer Therapeutics

ACS Med Chem Lett. 2020 May 18;11(6):1090-1091. doi: 10.1021/acsmedchemlett.0c00235.

Robert B Kargbo ¹

Affiliations

Affiliation

1 Usona Institute, 277 Granada Drive, San Luis Obispo, California 93401-7337, United States.

PMID: 32550985 DOI: 10.1021/acsmedchemlett.0c00235

MedChemExpress Magic Cece

MedChemExpress: Contact Us; About Us; Headquarters; Distributors; Statement on False Report; Careers

Customer Support: Technical Support; Service; Ordering Information; Easy Return; Shipping Rates & Policies; Intellectual Property Promise

Resources: Free Sample; Resources; Molarity Calculator; Dilution Calculator; Terms & Conditions; Reconstitution Calculator; Specific Activity Calculator; DNA/RNA sequence conversion tools

Subscribe to our E-newsletter

Name
Email *

	Sorry, but the email address you supplied was invalid.

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.

Copyright © 2013-2025 MedChemExpress. All Rights Reserved.: Site Map Privacy Policy

Join with us